INTERNATIONAL PATENT: FOUNDATION MEDICINE, INC. FILES APPLICATION FOR "USE OF FIBROBLAST GROWTH FACTOR RECEPTOR 3 MUTATIONS AND TUMOR MUTATIONAL BURDEN TO PREDICT RESPONSE TO IMMUNOTHERAPIES"

GENEVA, June 19 -- FOUNDATION MEDICINE, INC. (400 Summer StreetBoston, MA 02210) filed a patent application (PCT/US2024/058849) for "USE OF FIBROBLAST GROWTH FACTOR RECEPTOR 3 MUTATIONS AND TUMOR MUTATIONAL BURDEN TO PREDICT RESPONSE TO IMMUNOTHERAPIES" on Dec 06, 2024. With publication no. WO/2025/122856, the details related to the patent application was published on Jun 12, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LEE, Jessica, K. (c/o Foundation Medicine, Inc.400 Summer StreetBoston, MA 02210), HUANG, Richard, Sheng, Poe (c/o Foundation Medicine, Inc.400 Summer StreetBoston, MA 022...